Cargando…
Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
Prediction of prostate cancer in primary care is typically based upon serum total prostate-specific antigen (tPSA) and digital rectal examination results. However, these tests lack sensitivity and specificity, leading to over-diagnosis of disease and unnecessary, invasive biopsies. Therefore, there...
Autores principales: | McNally, Christopher J, Ruddock, Mark W, Moore, Tara, McKenna, Declan J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335899/ https://www.ncbi.nlm.nih.gov/pubmed/32669872 http://dx.doi.org/10.2147/CMAR.S250829 |
Ejemplares similares
-
A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into “Low-” and “High-Risk” Categories for Prostate Cancer
por: McNally, Christopher J., et al.
Publicado: (2022) -
MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer
por: Angel, Charlotte Zoe, et al.
Publicado: (2023) -
Benign Prostatic Hyperplasia
Publicado: (2015) -
The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
por: Thomas, Dominique, et al.
Publicado: (2019) -
Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)